Búsqueda | Biblioteca Virtual en Salud Odontología. Uruguay

1.

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.

Ann Oncol ; 35(6): 537-548, 2024 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-38844309

2.

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.

El-Khoueiry, A B; Trojan, J; Meyer, T; Yau, T; Melero, I; Kudo, M; Hsu, C; Kim, T-Y; Choo, S-P; Kang, Y-K; Yeo, W; Chopra, A; Soleymani, S; Yao, J; Neely, J; Tschaika, M; Welling, T H; Sangro, B.

Ann Oncol ; 35(4): 381-391, 2024 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-38151184

3.

AEDV Expert Consensus Document on the Organization of a Multidisciplinary Unit for Patients With or at Risk of Venereal Infections. / Documento de expertos de la Academia Española de Dermatología y Venereología sobre la organización de una unidad multidisciplinar de atención a pacientes con o en riesgo de infecciones venéreas.

Riera-Monroig, J; Feltes-Ochoa, R A; Quiles-Melero, I; Martin-Gorgojo, A.

Actas Dermosifiliogr ; 115(6): 583-591, 2024 Jun.

Artículo en Inglés, Español | MEDLINE | ID: mdl-38373604

4.

Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.

Araujo, D; Greystoke, A; Bates, S; Bayle, A; Calvo, E; Castelo-Branco, L; de Bono, J; Drilon, A; Garralda, E; Ivy, P; Kholmanskikh, O; Melero, I; Pentheroudakis, G; Petrie, J; Plummer, R; Ponce, S; Postel-Vinay, S; Siu, L; Spreafico, A; Stathis, A; Steeghs, N; Yap, C; Yap, T A; Ratain, M; Seymour, L.

Ann Oncol ; 34(1): 48-60, 2023 01.

Artículo en Inglés | MEDLINE | ID: mdl-36182023

5.

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT).

Marabelle, A; Andtbacka, R; Harrington, K; Melero, I; Leidner, R; de Baere, T; Robert, C; Ascierto, P A; Baurain, J-F; Imperiale, M; Rahimian, S; Tersago, D; Klumper, E; Hendriks, M; Kumar, R; Stern, M; Öhrling, K; Massacesi, C; Tchakov, I; Tse, A; Douillard, J-Y; Tabernero, J; Haanen, J; Brody, J.

Ann Oncol ; 29(11): 2163-2174, 2018 11 01.

Artículo en Inglés | MEDLINE | ID: mdl-30295695

6.

Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients.

Rodríguez-Ruiz, M E; Perez-Gracia, J L; Rodríguez, I; Alfaro, C; Oñate, C; Pérez, G; Gil-Bazo, I; Benito, A; Inogés, S; López-Diaz de Cerio, A; Ponz-Sarvise, M; Resano, L; Berraondo, P; Barbés, B; Martin-Algarra, S; Gúrpide, A; Sanmamed, M F; de Andrea, C; Salazar, A M; Melero, I.

Ann Oncol ; 29(5): 1312-1319, 2018 05 01.

Artículo en Inglés | MEDLINE | ID: mdl-29554212

7.

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Sánchez-Paulete, A R; Teijeira, A; Cueto, F J; Garasa, S; Pérez-Gracia, J L; Sánchez-Arráez, A; Sancho, D; Melero, I.

Ann Oncol ; 28(suppl_12): xii44-xii55, 2017 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-28945841

8.

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.

Sanmamed, M F; Perez-Gracia, J L; Schalper, K A; Fusco, J P; Gonzalez, A; Rodriguez-Ruiz, M E; Oñate, C; Perez, G; Alfaro, C; Martín-Algarra, S; Andueza, M P; Gurpide, A; Morgado, M; Wang, J; Bacchiocchi, A; Halaban, R; Kluger, H; Chen, L; Sznol, M; Melero, I.

Ann Oncol ; 28(8): 1988-1995, 2017 Aug 01.

Artículo en Inglés | MEDLINE | ID: mdl-28595336

9.

Harmful cytokines in cancer immunology and immunotherapy: biomarkers and targets?

Melero, I; Normanno, N.

Ann Oncol ; 32(11): 1311-1313, 2021 11.

Artículo en Inglés | MEDLINE | ID: mdl-34560240

10.

Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapy.

Sznol, M; Melero, I.

Ann Oncol ; 32(3): 295-297, 2021 03.

Artículo en Inglés | MEDLINE | ID: mdl-33307201

11.

Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies.

Sanmamed, M F; Chester, C; Melero, I; Kohrt, H.

Ann Oncol ; 27(7): 1190-8, 2016 07.

Artículo en Inglés | MEDLINE | ID: mdl-26912558

12.

Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression.

Unzu, C; Melero, I; Hervás-Stubbs, S; Sampedro, A; Mancheño, U; Morales-Kastresana, A; Serrano-Mendioroz, I; de Salamanca, R E; Benito, A; Fontanellas, A.

Gene Ther ; 22(11): 856-65, 2015 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-26125605

13.

[Translated article] Descriptive study of spinal instrumentation-related infections in a tertiary hospital.

Rico Nieto, A; Loeches Yagüe, B; Quiles Melero, I; Talavera Buedo, G; Pizones, J; Fernández-Baillo Sacristana, N.

Rev Esp Cir Ortop Traumatol ; 68(3): T201-T208, 2024.

Artículo en Inglés, Español | MEDLINE | ID: mdl-38232934

14.

Descriptive study of spinal instrumentation-related infections in a tertiary hospital. / Estudio descriptivo de las infecciones asociadas con instrumentación de columna en un hospital terciario.

Rico Nieto, A; Loeches Yagüe, B; Quiles Melero, I; Talavera Buedo, G; Pizones, J; Fernández-Baillo Sacristana, N.

Rev Esp Cir Ortop Traumatol ; 2023 Sep 09.

Artículo en Inglés, Español | MEDLINE | ID: mdl-37690513

15.

Epidemiology and prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium in a tertiary hospital from Madrid, Spain.

Maldonado-Barrueco, A; Rodríguez-Ayala, M; Grandioso-Vas, D; García-Clemente, P; Guedez-López, G V; García-Rodríguez, J; Quiles-Melero, I.

Rev Esp Quimioter ; 36(3): 310-313, 2023 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-36896655

16.

Prevalence of mutations associated with macrolide and fluoroquinolone resistance in Neisseria gonorrhoeae with Allplex NG-DR Assay (Seegene) in a tertiary hospital from Madrid, Spain.

Maldonado-Barrueco, A; Sanz-González, C; Falces-Romero, I; García-Clemente, P; Cacho-Calvo, J; Quiles-Melero, I.

Rev Esp Quimioter ; 36(6): 625-628, 2023 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-37721708

17.

Cancer immunotherapy full speed ahead.

Melero, I; Navarro, B; Teijeira, A; Coukos, G.

Ann Oncol ; 28(suppl_12): xii1-xii2, 2017 12 01.

Artículo en Inglés | MEDLINE | ID: mdl-29253117

18.

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Sánchez-Paulete, A R; Teijeira, A; Cueto, F J; Garasa, S; Pérez-Gracia, J L; Sánchez-Arráez, A; Sancho, D; Melero, I.

Ann Oncol ; 28(suppl_12): xii74, 2017 12 01.

Artículo en Inglés | MEDLINE | ID: mdl-29253116

19.

Evaluation of matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry for identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis.

Quiles-Melero, I; García-Rodríguez, J; Gómez-López, A; Mingorance, J.

Eur J Clin Microbiol Infect Dis ; 31(1): 67-71, 2012 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-21547602

20.

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.

Tabernero, J; Andre, F; Blay, J-Y; Bustillos, A; Fear, S; Ganta, S; Jaeger, D; Maio, M; Mileshkin, L; Melero, I.

ESMO Open ; 7(2): 100419, 2022 04.

Artículo en Inglés | MEDLINE | ID: mdl-35305400

Biblioteca Virtual en Salud Odontología. Uruguay

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.

Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT).

Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients.

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.

Harmful cytokines in cancer immunology and immunotherapy: biomarkers and targets?

Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapy.

Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies.

Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression.

[Translated article] Descriptive study of spinal instrumentation-related infections in a tertiary hospital.

Descriptive study of spinal instrumentation-related infections in a tertiary hospital. / Estudio descriptivo de las infecciones asociadas con instrumentación de columna en un hospital terciario.

Epidemiology and prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium in a tertiary hospital from Madrid, Spain.

Prevalence of mutations associated with macrolide and fluoroquinolone resistance in Neisseria gonorrhoeae with Allplex NG-DR Assay (Seegene) in a tertiary hospital from Madrid, Spain.

Cancer immunotherapy full speed ahead.

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Evaluation of matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry for identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis.

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.